Eledon Pharmaceuticals, Inc. (ELDN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 123.57M |
| Enterprise Value | 101.41M |
| P/E Ratio | -2.8 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.38 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -2.57 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.78 |
| Return On Equity | -1.36 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -45.27M |
| Net Income | -45.62M |
| Diluted EPS | -0.56 |
Balance Sheet
| Total Cash | 88.76M |
| Total Cash/Share | 0.78 |
| Total Debt | 467,000 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 7.9 |
| Book Value Per Share | 0.63 |
Price History
| 52-Week Change | 9.26 |
| 52-Week High | 4.6 |
| 52-Week Low | 1.35 |
| Moving Average 50 Days | 3.55 |
| Moving Average 200 Days | 2.95 |
Statistics
| Average Volume | 1.29M |
| Shares Outstanding | 77.19M |
| % Held by Institutions | 41.47 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:18 |
| Last Split Date | October 05, 2020 |
AD
